The Patient Ratings and comments are gathered from our Patient Satisfaction Survey and displayed in their entirety.
Stay Connected. Manage Your Care.
Access your health information anytime and anywhere, at home or on the go, with MyHealth.
- Message your clinic
- View your lab results
- Schedule your next appointment
- Pay your bill
The MyHealth mobile app from Stanford Health Care puts all your health information at your fingertips and makes managing your health care simple and quick.
Guest Services
24/7
We are available to assist you
whenever you need it. Give us a call at
650-498-3333 or
PHYSICIAN HELPLINE
Have a question? We're here to help! Call 1-866-742-4811
Monday - Friday, 8 a.m. - 5 p.m.
REFER A PATIENT
Fax 650-320-9443
Track your patients' progress and communicate with Stanford providers conveniently and securely.
Viswam S. Nair, MD MS
Pulmonologist
Practice Areas
Professional Education
- Fellowship: Stanford University Division of PCCM (2010) CA
- Residency: Santa Clara Valley Medical Center (2007) CA
- Medical Education: Ohio State University (2004) OH
- Board Certification: Critical Care Medicine, American Board of Internal Medicine (2010)
- Bachelor of Arts, University of Pennsylvania, Chemistry (1998)
- Masters of Science, Stanford University, Clinical Epidemiology (2011)
- Board Certification: Internal Medicine, American Board of Internal Medicine (2007)
- Board Certification: Pulmonary Disease, American Board of Internal Medicine (2009)
- Board Certification, Critical Care Medicine, American Board of Internal Medicine (2010)
Honors & Awards
- PET-FDG uptake, gene expression and outcome in stage I resected lung adenocarcinoma, The CHEST Foundation, Clinical Research Award (07/09-07/10)
- An analysis of early-stage NSCLC transcriptomics across varying FDG uptake levels on PET imaging, Lung Cancer Research Foundation (11/10-11/11)
- In vivo and in vitro diagnostics for assessing the lung nodule, LUNGevity Foundation Career Development Award (07/12-07/15)
- Loan Repayment Program "In vivo and In vitro diagnostics to improve lung cancer care", NIH NCI (10/13-10/15)
- Corr. of High-Res Imaging of Regional Lung Vent. by Single Energy CT with SPECT Vent. Images, Stanford Bio-X IIP Seed Grant (2015)
Administrative Appointments
- Associate Member, Canary Center at Stanford for Cancer Early Detection (2013 - Present)
- Co-Director, Lung Stanford Nodule Assessment Program (Lung-SNAP) (2013 - Present)
- Assistant Director, Lung Cancer Screening Program, Stanford (2014 - Present)
Publications
-
Integrating Tumor and Stromal Gene Expression Signatures With Clinical Indices for Survival Stratification of Early-Stage Non-Small Cell Lung Cancer.
Gentles, A. J., Bratman, S. V., Lee, L. J., Harris, J. P., Feng, W., & Diehn, M. (2015). Integrating Tumor and Stromal Gene Expression Signatures With Clinical Indices for Survival Stratification of Early-Stage Non-Small Cell Lung Cancer. Journal of the National Cancer Institute, 107(10). -
The prognostic landscape of genes and infiltrating immune cells across human cancers
Gentles, A. J., Newman, A. M., Liu, C. L., Bratman, S. V., Feng, W., & Alizadeh, A. A. (2015). The prognostic landscape of genes and infiltrating immune cells across human cancers. NATURE MEDICINE, 21(8), 938-945. -
Circulating Tumor Microemboli Diagnostics for Patients with Non-Small-Cell Lung Cancer
Carlsson, A., Nair, V. S., Luttgen, M. S., Keu, K. V., Horng, G., & Gambhir, S. S. (2014). Circulating Tumor Microemboli Diagnostics for Patients with Non-Small-Cell Lung Cancer. JOURNAL OF THORACIC ONCOLOGY, 9(8), 1111-1119. -
Design and Analysis for Studying microRNAs in Human Disease: A Primer on -Omic Technologies
Nair, V. S., Pritchard, C. C., Tewari, M., & Ioannidis, J. Pa. (2014). Design and Analysis for Studying microRNAs in Human Disease: A Primer on -Omic Technologies. AMERICAN JOURNAL OF EPIDEMIOLOGY, 180(2), 140-152.
-
NF-kappa B protein expression associates with F-18-FDG PET tumor uptake in non-small cell lung cancer: A radiogenomics validation study to understand tumor metabolism
Nair, V. S., Gevaert, O., Davidzon, G., Plevritis, S. K., & West, R. (2014). NF-kappa B protein expression associates with F-18-FDG PET tumor uptake in non-small cell lung cancer: A radiogenomics validation study to understand tumor metabolism. LUNG CANCER, 83(2), 189-196.
-
A Dominant Adenocarcinoma With Multifocal Ground Glass Lesions Does Not Behave as Advanced Disease
Gu, B., Burt, B. M., Merritt, R. E., Stephanie, S., Nair, V., & Shrager, J. B. (2013). A Dominant Adenocarcinoma With Multifocal Ground Glass Lesions Does Not Behave as Advanced Disease. ANNALS OF THORACIC SURGERY, 96(2), 411-418.
-
An Observational Study of Circulating Tumor Cells and F-18-FDG PET Uptake in Patients with Treatment-Naive Non-Small Cell Lung Cancer
Nair, V. S., Keu, K. V., Luttgen, M. S., Kolatkar, A., Vasanawala, M., & Kuhn, P. (2013). An Observational Study of Circulating Tumor Cells and F-18-FDG PET Uptake in Patients with Treatment-Naive Non-Small Cell Lung Cancer. PLOS ONE, 8(7).
-
Circulating tumour cells in early breast cancer
Nair, V. S., Keu, K. V., Kuhn, P., & Gambhir, S. S. (2012). Circulating tumour cells in early breast cancer. LANCET ONCOLOGY, 13(9), E370-E371.
-
Prognostic PET F-18-FDG Uptake Imaging Features Are Associated with Major Oncogenomic Alterations in Patients with Resected Non-Small Cell Lung Cancer
Nair, V. S., Gevaert, O., Davidzon, G., Napel, S., Graves, E. E., & Plevritis, S. K. (2012). Prognostic PET F-18-FDG Uptake Imaging Features Are Associated with Major Oncogenomic Alterations in Patients with Resected Non-Small Cell Lung Cancer. CANCER RESEARCH, 72(15), 3725-3734.
-
Clinical Outcome Prediction by MicroRNAs in Human Cancer: A Systematic Review
Nair, V. S., Maeda, L. S., & Ioannidis, J. Pa. (2012). Clinical Outcome Prediction by MicroRNAs in Human Cancer: A Systematic Review. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 104(7), 528-540.
-
Fluorodeoxyglucose-PET Scanning in the Diagnosis of Pleural Disease
Nair, V. S. (2011). Fluorodeoxyglucose-PET Scanning in the Diagnosis of Pleural Disease. CHEST, 139(4), 966-967.
-
PET Scan F-18-Fluorodeoxyglucose Uptake and Prognosis in Patients With Resected Clinical Stage IA Non-small Cell Lung Cancer
Nair, V. S., Barnett, P. G., Ananth, L., & Gould, M. K. (2010). PET Scan F-18-Fluorodeoxyglucose Uptake and Prognosis in Patients With Resected Clinical Stage IA Non-small Cell Lung Cancer. CHEST, 137(5), 1150-1156.
-
Management of Lung Nodules Detected by Volume CT Scanning
Nair, V. S. (2010). Management of Lung Nodules Detected by Volume CT Scanning. NEW ENGLAND JOURNAL OF MEDICINE, 362(8), 757-757.
-
Positron Emission Tomography F-18-Fluorodeoxyglucose Uptake and Prognosis in Patients with Surgically Treated, Stage I Non-small Cell Lung Cancer: A Systematic Review
Nair, V. S., Krupitskaya, Y., & Gould, M. K. (2009). Positron Emission Tomography F-18-Fluorodeoxyglucose Uptake and Prognosis in Patients with Surgically Treated, Stage I Non-small Cell Lung Cancer: A Systematic Review. JOURNAL OF THORACIC ONCOLOGY, 4(12), 1473-1479.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Patient Comments
Patients comments are gathered from our Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
SHC Patient, Sep 2015
They are excellent.
SHC Patient, Mar 2015
Spent most time with Dr. Sharifi. Fantastic doctor: Thorough, attentive, caring and gave a good plan for treatment.
SHC Patient, Jan 2015
Dr. Nair is one of the best drs. I have/had he saved my life!
SHC Patient, Nov 2014
Dr. Nair spent quality time and explained and verified all.
SHC Patient, Sep 2014
I need to change pulmonary doctor. I have no confidence in this doctor. He does not give me results of test he just go on with procedures.
SHC Patient, Apr 2014
Excellent.
SHC Patient, Sep 2015
They are excellent.
SHC Patient, Mar 2015
Spent most time with Dr. Sharifi. Fantastic doctor: Thorough, attentive, caring and gave a good plan for treatment.
SHC Patient, Jan 2015
Dr. Nair is one of the best drs. I have/had he saved my life!
SHC Patient, Nov 2014
Dr. Nair spent quality time and explained and verified all.
SHC Patient, Sep 2014
I need to change pulmonary doctor. I have no confidence in this doctor. He does not give me results of test he just go on with procedures.
SHC Patient, Apr 2014
Excellent.